International Biotechnology Trust as of Dec. 31, 2016
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 49 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 9.5 | $21M | 182k | 115.79 | |
| Biogen Idec (BIIB) | 8.4 | $19M | 66k | 283.62 | |
| Alexion Pharmaceuticals | 7.4 | $16M | 134k | 122.35 | |
| Shire | 7.3 | $16M | 95k | 170.38 | |
| Tesaro | 5.7 | $13M | 95k | 134.44 | |
| Gilead Sciences (GILD) | 5.7 | $13M | 176k | 71.62 | |
| Regeneron Pharmaceuticals (REGN) | 5.4 | $12M | 32k | 367.25 | |
| Amgen (AMGN) | 5.3 | $12M | 80k | 146.23 | |
| Ariad Pharmaceuticals | 3.7 | $8.2M | 658k | 12.44 | |
| Incyte Corporation (INCY) | 3.6 | $7.9M | 79k | 100.26 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $7.8M | 106k | 73.73 | |
| Entellus Medical Cm | 3.4 | $7.6M | 403k | 18.92 | |
| Illumina (ILMN) | 3.2 | $7.2M | 56k | 128.03 | |
| BioMarin Pharmaceutical (BMRN) | 2.8 | $6.3M | 76k | 82.82 | |
| Aerie Pharmaceuticals | 2.4 | $5.2M | 138k | 37.75 | |
| Clovis Oncology | 1.5 | $3.3M | 75k | 44.43 | |
| Intercept Pharmaceuticals In | 1.4 | $3.2M | 30k | 108.64 | |
| Adamas Pharmaceuticals | 1.4 | $3.1M | 185k | 16.90 | |
| Ligand Pharmaceuticals In (LGND) | 1.4 | $3.0M | 30k | 101.60 | |
| Exelixis (EXEL) | 1.2 | $2.8M | 185k | 14.91 | |
| Foamix Pharmaceuticals | 1.0 | $2.2M | 198k | 11.10 | |
| Vanda Pharmaceuticals (VNDA) | 1.0 | $2.2M | 136k | 15.95 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $2.2M | 322k | 6.78 | |
| Prothena (PRTA) | 0.9 | $2.1M | 42k | 49.19 | |
| Jazz Pharmaceuticals (JAZZ) | 0.9 | $2.0M | 18k | 109.01 | |
| Synergy Pharmaceuticals | 0.9 | $1.9M | 312k | 6.09 | |
| Alder Biopharmaceuticals | 0.8 | $1.7M | 80k | 20.80 | |
| Kite Pharma | 0.7 | $1.6M | 37k | 44.85 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $1.6M | 40k | 38.69 | |
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $1.5M | 51k | 28.84 | |
| Neuroderm Ltd F | 0.7 | $1.4M | 65k | 22.11 | |
| Horizon Pharma | 0.6 | $1.4M | 85k | 16.16 | |
| Dermira | 0.6 | $1.4M | 45k | 30.31 | |
| Xencor (XNCR) | 0.6 | $1.3M | 48k | 26.31 | |
| Trillium Therapeutics, Inc. Cmn | 0.6 | $1.3M | 222k | 5.65 | |
| Transenterix | 0.5 | $1.2M | 889k | 1.30 | |
| Macrogenics (MGNX) | 0.5 | $1.1M | 54k | 20.43 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $903k | 59k | 15.31 | |
| Sage Therapeutics (SAGE) | 0.4 | $867k | 17k | 51.01 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $838k | 7.5k | 111.73 | |
| Radius Health | 0.3 | $753k | 20k | 38.03 | |
| Nektar Therapeutics (NKTR) | 0.3 | $736k | 60k | 12.27 | |
| Array BioPharma | 0.3 | $571k | 65k | 8.78 | |
| Halozyme Therapeutics (HALO) | 0.3 | $572k | 58k | 9.86 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $576k | 21k | 27.43 | |
| Acceleron Pharma | 0.2 | $475k | 19k | 25.53 | |
| Acorda Therapeutics | 0.2 | $414k | 22k | 18.82 | |
| Adaptimmune Therapeutics (ADAP) | 0.2 | $387k | 96k | 4.01 | |
| Amicus Therapeutics (FOLD) | 0.1 | $273k | 55k | 4.96 |
